Durvalumab vs Norfloxacin

## Durvalumab vs Norfloxacin: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Norfloxacin**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Norfloxacin**: Second-generation fluoroquinolone inhibiting bacterial DNA gyrase and topoisomerase IV.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Norfloxacin — 3-4 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Norfloxacin — C16H18FN3O3.

**Molecular Weight**: Durvalumab — N/A; Norfloxacin — 319.3310 g/mol.

**Type**: Durvalumab — Antibody; Norfloxacin — Small molecule.